Key result
BAT-specific AQP1 knockout increases energy expenditure and protects mice against diet-induced obesity.
Why the study?
BAT activation is associated with improved cardiometabolic profiles, but the mechanisms that restrict brown adipose tissue in this state are unknown.
AQP1 acts as a silencer of brown adipose tissue, and its deletion increases energy expenditure and protects against diet-induced obesity in mice, highlighting it as a potential therapeutic target for metabolic dysfunction.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for AQP1 inhibition in obesity; human trials needed before clinical translation.
BAT activation is strongly associated with improved metabolic health such as enhanced cardiometabolic profiles. However, the mechanisms that restrict BAT in this state are unknown. We have identified a putative BAT silencer called AQP1 and through the creation of the first BAT-specific AQP1-KO mouse model, demonstrated that these mice have increased energy expenditure and protection against DIO. Thus, AQP1 is a promising therapeutic target for metabolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied Obesity and metabolic disease. BAT-specific AQP1 knockout was evaluated on Energy expenditure and protection against diet-induced obesity (DIO). BAT-specific AQP1-knockout mice demonstrated increased energy expenditure and protection against diet-induced obesity.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: